NASDAQ
No price data available for this timeframe.
Fate Therapeutics, Inc. (FATE) reported revenue of $6.65M and net income of $-136,315,000 for FY 2025, with a net profit margin of -2051.1%. Revenue represents total sales while net income is the profit remaining after all expenses. The relationship between them reflects overall profitability.